Futura Medical plc (LON:FUM – Get Free Report) shares rose 1.4% during trading on Tuesday . The company traded as high as GBX 0.25 and last traded at GBX 0.21. 162,214,766 shares changed hands during mid-day trading, an increase of 1,507% from the average daily volume of 10,092,442 shares. The stock had previously closed at GBX 0.21.
Futura Medical Stock Up 1.4%
The stock has a market cap of £1.24 million, a P/E ratio of -0.26 and a beta of 0.02. The firm has a 50 day moving average price of GBX 0.40 and a 200 day moving average price of GBX 0.76.
Futura Medical (LON:FUM – Get Free Report) last announced its quarterly earnings data on Tuesday, September 1st. The company reported GBX (0.20) earnings per share (EPS) for the quarter. Futura Medical had a negative net margin of 158.21% and a negative return on equity of 152.42%. Equities analysts predict that Futura Medical plc will post 2.8486672 earnings per share for the current fiscal year.
About Futura Medical
Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.
Featured Stories
- Five stocks we like better than Futura Medical
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
- AI Is Making Cybersecurity Harder to Ignore—These 3 ETFs Offer a Broad Bet
- Campbell’s Dividend Cut May Reset the Stock, But the Turnaround Still Has to Deliver
- Copper Is the AI Trade No One Priced In—3 Miners With the Most to Gain
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
